Skip to main content
AtriCure, Inc. logo

AtriCure, Inc. — Investor Relations & Filings

Ticker · ATRC ISIN · US04963C2098 LEI · 254900B2I6GPHK2EXM59 US Manufacturing
Filings indexed 1,189 across all filing types
Latest filing 2011-05-04 Earnings Release
Country US United States of America
Listing US ATRC

About AtriCure, Inc.

https://www.atricure.com

AtriCure, Inc. is a medical device company focused on developing, manufacturing, and selling technologies for the treatment of atrial fibrillation (Afib), management of the left atrial appendage (LAA), and post-operative pain. The company's product portfolio is primarily utilized by cardiothoracic surgeons and electrophysiologists. Key offerings include surgical ablation systems and the AtriClip® LAA Exclusion System, a widely implanted device for LAA management. Additionally, AtriCure provides cryoablation technology, such as the cryoXT™ Probe, which offers a non-opioid approach to pain management following surgical procedures, including amputation.

Recent filings

Filing Released Lang Actions
8-K Filing
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 4, 2011, reporting the company's financial results for the first quarter ended March 31, 2011. It mentions a press release and a conference call regarding these results. The document itself is a current report providing an update on earnings but does not contain detailed financial statements or comprehensive analysis. The length is 2780 characters, which is relatively short and consistent with an earnings release or initial announcement of quarterly results. The key phrase 'Results of Operations and Financial Condition' and the reference to a press release about Q1 results indicate this is an Earnings Release (ER).
2011-05-04 English
DEF 14A Filing
Proxy Solicitation & Information Statement
2011-04-18 English
4 Filing
Director's Dealing
2011-04-06 English
S-8 Filing
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as stock option plans. It includes details about the number of shares to be registered, the equity incentive plan, and signatures of company officers and directors. It is not a financial report, earnings release, or management discussion, but a regulatory filing related to securities registration. Therefore, it fits best under Regulatory Filings (RNS). The document length and content confirm it is the registration statement itself, not just an announcement.
2011-03-31 English
S-8 Filing
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans. It includes details about the registration of additional shares under the company's 2008 Employee Stock Purchase Plan. The document contains legal and regulatory information related to securities registration, including signatures and consents, but does not contain financial statements or performance data. This type of filing is a regulatory announcement related to securities registration and does not fit into categories like Annual Report, Earnings Release, or Capital/Financing Update. It is best classified under Regulatory Filings (RNS) as it is a compliance document filed with the SEC that does not fit other specific categories.
2011-03-31 English
10-K Filing
Annual Report FY 2010
2011-03-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.